These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 23150749)

  • 1. Therapeutic targeting of redox signaling in myofibroblast differentiation and age-related fibrotic disease.
    Sampson N; Berger P; Zenzmaier C
    Oxid Med Cell Longev; 2012; 2012():458276. PubMed ID: 23150749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox signaling as a therapeutic target to inhibit myofibroblast activation in degenerative fibrotic disease.
    Sampson N; Berger P; Zenzmaier C
    Biomed Res Int; 2014; 2014():131737. PubMed ID: 24701562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NADPH oxidase 4 is dispensable for skin myofibroblast differentiation and wound healing.
    Siedlar AM; Seredenina T; Faivre A; Cambet Y; Stasia MJ; André-Lévigne D; Bochaton-Piallat ML; Pittet-Cuénod B; de Seigneux S; Krause KH; Modarressi A; Jaquet V
    Redox Biol; 2023 Apr; 60():102609. PubMed ID: 36708644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activators and stimulators of soluble guanylate cyclase counteract myofibroblast differentiation of prostatic and dermal stromal cells.
    Zenzmaier C; Kern J; Heitz M; Plas E; Zwerschke W; Mattesich M; Sandner P; Berger P
    Exp Cell Res; 2015 Nov; 338(2):162-9. PubMed ID: 26410556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ROS signaling by NOX4 drives fibroblast-to-myofibroblast differentiation in the diseased prostatic stroma.
    Sampson N; Koziel R; Zenzmaier C; Bubendorf L; Plas E; Jansen-Dürr P; Berger P
    Mol Endocrinol; 2011 Mar; 25(3):503-15. PubMed ID: 21273445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Potential of sGC Modulators for the Treatment of Age-Related Fibrosis: A Mini-Review.
    Sandner P; Berger P; Zenzmaier C
    Gerontology; 2017; 63(3):216-227. PubMed ID: 27784018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor β1 (TGFβ1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis.
    Ghatak S; Hascall VC; Markwald RR; Feghali-Bostwick C; Artlett CM; Gooz M; Bogatkevich GS; Atanelishvili I; Silver RM; Wood J; Thannickal VJ; Misra S
    J Biol Chem; 2017 Jun; 292(25):10490-10519. PubMed ID: 28389561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases.
    Barnes JL; Gorin Y
    Kidney Int; 2011 May; 79(9):944-56. PubMed ID: 21307839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromodomain and Extraterminal (BET) Protein Inhibition Restores Redox Balance and Inhibits Myofibroblast Activation.
    Stock CJW; Michaeloudes C; Leoni P; Durham AL; Mumby S; Wells AU; Chung KF; Adcock IM; Renzoni EA; Lindahl GE
    Biomed Res Int; 2019; 2019():1484736. PubMed ID: 31119153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin attenuates myofibroblast differentiation and lung fibrosis development through proteasomal degradation of NOX4.
    Tsubouchi K; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Sato N; Yoshida M; Kurita Y; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Nakanishi Y; Kuwano K
    Autophagy; 2017 Aug; 13(8):1420-1434. PubMed ID: 28613983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
    Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
    Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NADPH oxidase 4 deficiency leads to impaired wound repair and reduced dityrosine-crosslinking, but does not affect myofibroblast formation.
    Lévigne D; Modarressi A; Krause KH; Pittet-Cuénod B
    Free Radic Biol Med; 2016 Jul; 96():374-84. PubMed ID: 27140231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin attenuates lung fibrosis development via NOX4 suppression.
    Sato N; Takasaka N; Yoshida M; Tsubouchi K; Minagawa S; Araya J; Saito N; Fujita Y; Kurita Y; Kobayashi K; Ito S; Hara H; Kadota T; Yanagisawa H; Hashimoto M; Utsumi H; Wakui H; Kojima J; Numata T; Kaneko Y; Odaka M; Morikawa T; Nakayama K; Kohrogi H; Kuwano K
    Respir Res; 2016 Aug; 17(1):107. PubMed ID: 27576730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro cultured fetal fibroblasts have myofibroblast-associated characteristics and produce a fibrotic-like environment upon stimulation with TGF-β1: Is there a thin line between fetal scarless healing and fibrosis?
    Walraven M; Akershoek JJ; Beelen RH; Ulrich MM
    Arch Dermatol Res; 2017 Mar; 309(2):111-121. PubMed ID: 28004279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
    Cho N; Razipour SE; McCain ML
    Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance.
    Hecker L; Logsdon NJ; Kurundkar D; Kurundkar A; Bernard K; Hock T; Meldrum E; Sanders YY; Thannickal VJ
    Sci Transl Med; 2014 Apr; 6(231):231ra47. PubMed ID: 24718857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the Hippo/TAZ pathway is required for menstrual stem cells to suppress myofibroblast and inhibit transforming growth factor β signaling in human endometrial stromal cells.
    Zhu H; Pan Y; Jiang Y; Li J; Zhang Y; Zhang S
    Hum Reprod; 2019 Apr; 34(4):635-645. PubMed ID: 30715393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trichostatin A inhibits transforming growth factor-β-induced reactive oxygen species accumulation and myofibroblast differentiation via enhanced NF-E2-related factor 2-antioxidant response element signaling.
    Yang L; Qu M; Wang Y; Duan H; Chen P; Wang Y; Shi W; Danielson P; Zhou Q
    Mol Pharmacol; 2013 Mar; 83(3):671-80. PubMed ID: 23284002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardin-related Transcription Factor Regulates Nox4 Protein Expression: LINKING CYTOSKELETAL ORGANIZATION TO REDOX STATE.
    Rozycki M; Bialik JF; Speight P; Dan Q; Knudsen TE; Szeto SG; Yuen DA; Szászi K; Pedersen SF; Kapus A
    J Biol Chem; 2016 Jan; 291(1):227-43. PubMed ID: 26555261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphodiesterase type 5 inhibition reverts prostate fibroblast-to-myofibroblast trans-differentiation.
    Zenzmaier C; Kern J; Sampson N; Heitz M; Plas E; Untergasser G; Berger P
    Endocrinology; 2012 Nov; 153(11):5546-55. PubMed ID: 22948216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.